Respiratory News and Research

RSS

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Research indicates that hyperglycemia puts pediatric burns patients at increased risk for pneumonia.

8 Oct 2013

Smoking during pregnancy may affect child’s immune system on molecular level

The Leipzig Helmholtz Center for Environmental Research has gained new insights on the influence of tobacco smoke in utero. For the first time, it could be demonstrated with smoking pregnant women and their children, how exposure to tobacco smoke affects the development of human immune system on molecular level.

8 Oct 2013

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Eddingpharm continued to aggressively build its product portfolio by inking another cancer agreement, this time with Immutep. In this latest agreement, Eddingpharm was granted exclusive rights to develop and market ImmuFact® IMP321 in mainland China, Hong Kong, Macau, and Taiwan.

7 Oct 2013

Study finds association between heart failure and air pollution

Air pollution increases heart attacks, according to research presented at the Acute Cardiac Care Congress 2013 by Dr Savina Nodari from Brescia, Italy.

7 Oct 2013

Study shows how evolution shaped lungs through successive optimizations of physical parameters

Two French physicists, Bernard Sapoval and Marcel Filoche from -cole Polytechnique in Palaiseau, France, suggest in a study published in EPJ E how evolution has shaped our lungs through successive optimisations of physical parameters such as conservation of energy and speed of delivery.

7 Oct 2013

Newly discovered compound could be developed as antifungal drug to treat fungal infections

On a molecular level, you have more in common with shower curtain mold or the mushrooms on your pizza than you might think. Humans and fungi share similar proteins, a biological bond that makes curing fungal infections difficult and expensive.

7 Oct 2013

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

AbbVie (NYSE: ABBV) today announced results from a post-hoc analysis of an investigational Phase II study, which evaluated HUMIRA® (adalimumab) in the treatment of patients with moderate-to-severe hidradenitis suppurativa (HS) after 16 weeks of therapy.

7 Oct 2013

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Discovery Laboratories, Inc. (NASDAQ: DSCO), a specialty biotechnology company dedicated to advancing a new standard in respiratory critical care, today announced the U.S. Food and Drug Administration (FDA) has agreed to the Company's updated product specifications for SURFAXIN® (lucinactant) Intratracheal Suspension which was approved for the prevention of respiratory distress syndrome (RDS) in premature infants at high risk for RDS.

5 Oct 2013

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013.

5 Oct 2013

Asthma alert in very physically active

Research from Sweden shows that while people with asthma are as likely to be mildly active or inactive as people without, there is a strong relationship between vigorous physical activity and the respiratory condition.

3 Oct 2013

Gas transfer excels in predicting mortality in COPD

Researchers say that measuring gas transfer is the most effective way to predict mortality in chronic obstructive pulmonary disease, after finding that it outperformed both spirometry and plethysmography for the purpose.

3 Oct 2013

X-Chem, Astrazeneca Expand Drug Discovery Collab

...

3 Oct 2013

'Early-term' babies more likely to experience higher risk for adverse health outcomes

Babies considered "early-term," born at 37 or 38 weeks after a mother's last menstrual period, may look as healthy as full-term babies born at 39-41 weeks, but a new study published by University at Buffalo physicians in JAMA Pediatrics has found that many of them are not.

3 Oct 2013

Researchers to develop nerve agent antidotes that can be used during chemical warfare

Ever since World War II, nerve agents have been a concern in modern warfare and up until now, the only antidotes available acted after the agents damaged the nervous system.

3 Oct 2013

New research shows no increased danger for egg allergic children who take flu shots

All children should have flu shots, even if they have an egg allergy, and it's now safe to get them without special precautions. This finding is from the latest update on the safety of the flu vaccine for allergic patients, published in the October issue of the Annals of Allergy, Asthma and Immunology, the official journal of the American College of Allergy, Asthma and Immunology.

2 Oct 2013

NIH awards 10 new grants to support genomics research in Africa

The National Institutes of Health has awarded 10 new grants totaling up to $17 million over the next four years to support genomics research in Africa, as part of the Human Heredity and Health in Africa (H3Africa) program

2 Oct 2013

Precise value of EXACT in COPD uncertain

EXACT is effective in assessing exacerbations of chronic obstructive pulmonary disease in the outpatient setting, a study shows.

1 Oct 2013

Early-term births associated with higher neonatal morbidity, shows study

Early-term births (37 to 38 weeks gestation) are associated with higher neonatal morbidity (illness) and with more neonatal intensive care unit (NICU) or neonatology service admissions than term births (39 to 41 weeks gestation), according to a study by Shaon Sengupta, M.D., M.P.H., now of the Children's Hospital of Philadelphia and formerly of the University at Buffalo, N.Y., and colleagues.

1 Oct 2013

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

Influenza strikes five to 15 percent of the population and is estimated to cost the U.S. economy a hefty $90 million per year. If researchers can improve the understanding of how environmental conditions affect the ability of the influenza virus to survive and infect others while it is airborne, they may be able to help improve prediction and control of its spread.

1 Oct 2013

MD Anderson-developed aerosol triggers innate immunity to squelch infections

Research on an aerosol that jump-starts a rapid immune response to stifle viral respiratory infections before they can provoke asthma attacks has earned major funding from the National Institutes of Health.

1 Oct 2013

Respiratory News and Research

Hyperglycemia heightens pneumonia risk in pediatric burns patients

Smoking during pregnancy may affect child’s immune system on molecular level

Eddingpharm Secures Immutep’s Immufact IMP321 For Growing Stable

Study finds association between heart failure and air pollution

Study shows how evolution shaped lungs through successive optimizations of physical parameters

Newly discovered compound could be developed as antifungal drug to treat fungal infections

AbbVie announces HUMIRA phase II study results for treating hidradenitis suppurativa

FDA approves Discovery Lab’s updated product specifications for SURFAXIN lucinactant

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Asthma alert in very physically active

Gas transfer excels in predicting mortality in COPD

X-Chem, Astrazeneca Expand Drug Discovery Collab

'Early-term' babies more likely to experience higher risk for adverse health outcomes

Researchers to develop nerve agent antidotes that can be used during chemical warfare

New research shows no increased danger for egg allergic children who take flu shots

NIH awards 10 new grants to support genomics research in Africa

Precise value of EXACT in COPD uncertain

Early-term births associated with higher neonatal morbidity, shows study

Virginia Tech faculty receives NIH New Innovator Award to research on influenza transmission

MD Anderson-developed aerosol triggers innate immunity to squelch infections

How can microdialysis benefit drug development

Global and Local Efforts to Take Action Against Hepatitis

Addressing Important Cardiac Biology Questions with Shotgun Top-Down Proteomics

Latest News